Valeant Pharmaceuticals International Inc. (NYSE: VRX) saw its shares hit a multiyear low on Tuesday after it was announced that Bill Ackman would be selling off his stake in the company and stepping down from the board. Unfortunately for Valeant, with Ackman’s departure he seems to be screaming abandon ship.
